I Chandler1, R S Houlston. 1. Department of Cellular Pathology, St George's Hospital, London, and Section of Cancer Genetics, Institute of Cancer Research, Sutton, UK. ian.chandler@icr.ac.uk
Abstract
AIMS: Tumour grade represents a gestalt of all molecular changes in malignancy, reflecting aggressiveness and has been shown to add prognostic information independent of stage for many malignancies, including colorectal cancer. Despite the grade of colorectal cancer being reported routinely in the UK, there is paucity of data on the level of agreement between histopathologists and hence the value of this metric in clinical practice. The aim was to estimate the degree of inter-observer variation in grading by conducting a nationwide web-based survey of histopathologists. METHODS AND RESULTS: Individuals were asked to grade a series of 20 tumours. Data from 104 pathologists surveyed indicates that agreement using both two and three grade systems is at best fair. CONCLUSION: Given that for the foreseeable future the histopathological criteria of stage and grade will still provide the mainstay of prognostication and therefore clinical decision-making, efforts should be made to improve grading criteria and standardize use of the low- and high-grade categories.
AIMS: Tumour grade represents a gestalt of all molecular changes in malignancy, reflecting aggressiveness and has been shown to add prognostic information independent of stage for many malignancies, including colorectal cancer. Despite the grade of colorectal cancer being reported routinely in the UK, there is paucity of data on the level of agreement between histopathologists and hence the value of this metric in clinical practice. The aim was to estimate the degree of inter-observer variation in grading by conducting a nationwide web-based survey of histopathologists. METHODS AND RESULTS: Individuals were asked to grade a series of 20 tumours. Data from 104 pathologists surveyed indicates that agreement using both two and three grade systems is at best fair. CONCLUSION: Given that for the foreseeable future the histopathological criteria of stage and grade will still provide the mainstay of prognostication and therefore clinical decision-making, efforts should be made to improve grading criteria and standardize use of the low- and high-grade categories.
Authors: Rashid L Bashshur; Elizabeth A Krupinski; Ronald S Weinstein; Matthew R Dunn; Noura Bashshur Journal: Telemed J E Health Date: 2017-02-07 Impact factor: 3.536
Authors: Sibylle Gündisch; Julia Slotta-Huspenina; Paolo Verderio; Chiara Maura Ciniselli; Sara Pizzamiglio; Christina Schott; Enken Drecoll; Christian Viertler; Kurt Zatloukal; Marcel Kap; Peter Riegman; Irene Esposito; Katja Specht; Gregor Babaryka; Martin Asslaber; Koppany Bodó; Michael den Bakker; Jan den Hollander; Falko Fend; Jens Neumann; Simone Reu; Aurel Perren; Rupert Langer; Alessandro Lugli; Ingrid Becker; Thomas Richter; Gian Kayser; Annette M May; Fatima Carneiro; José Manuel Lopes; Leslie Sobin; Heinz Höfler; Karl-Friedrich Becker Journal: Virchows Arch Date: 2014-08-02 Impact factor: 4.064
Authors: Annika Resch; Lars Harbaum; Marion J Pollheimer; Peter Kornprat; Richard A Lindtner; Cord Langner Journal: Int J Colorectal Dis Date: 2016-01-26 Impact factor: 2.571
Authors: Ch Kakies; A Lopez-Beltran; E Comperat; A Erbersdobler; R Grobholz; O W Hakenberg; A Hartmann; L-C Horn; A K Höhn; J Köllermann; G Kristiansen; R Montironi; M Scarpelli; Ch Protzel Journal: Virchows Arch Date: 2014-02-18 Impact factor: 4.064